(-0.18%) 5 061.58 points
(-0.18%) 38 433 points
(-0.17%) 15 669 points
(-0.59%) $82.87
(-8.22%) $1.663
(-0.39%) $2 332.90
(-0.35%) $27.27
(-1.01%) $913.45
(0.11%) $0.935
(0.79%) $10.99
(-0.01%) $0.803
(-0.98%) $92.27
Live Chart Being Loaded With Signals
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery...
Stats | |
---|---|
Today's Volume | 7.43M |
Average Volume | 5.82M |
Market Cap | 5.52B |
EPS | £0.0361 ( 2023-08-31 ) |
Last Dividend | £0.0443 ( 2020-03-19 ) |
Next Dividend | £0 ( N/A ) |
P/E | 2 399.00 |
ATR14 | £0.166 (0.69%) |
Volume Correlation
Abcam plc Correlation
10 Most Positive Correlations | |
---|---|
ALGT | 0.963 |
MSAC | 0.953 |
MLAI | 0.95 |
KAII | 0.95 |
QUIK | 0.947 |
CAR | 0.946 |
GGAL | 0.944 |
BTBT | 0.944 |
ALSA | 0.943 |
LGAC | 0.943 |
10 Most Negative Correlations | |
---|---|
PRPO | -0.962 |
PSCH | -0.955 |
PSCC | -0.942 |
VORB | -0.942 |
PRFZ | -0.938 |
VIVE | -0.938 |
PTH | -0.937 |
ORPH | -0.935 |
PNQI | -0.935 |
SENEA | -0.932 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Abcam plc Correlation - Currency/Commodity
Abcam plc Financials
Annual | 2022 |
Revenue: | £361.70M |
Gross Profit: | £270.50M (74.79 %) |
EPS: | £-0.0372 |
Q2 | 2023 |
Revenue: | £101.60M |
Gross Profit: | £77.45M (76.23 %) |
EPS: | £0.0361 |
Q1 | 2023 |
Revenue: | £101.60M |
Gross Profit: | £77.45M (76.23 %) |
EPS: | £0.0361 |
Q4 | 2022 |
Revenue: | £166.70M |
Gross Profit: | £135.35M (81.19 %) |
EPS: | £-0.0410 |
Financial Reports:
No articles found.
Abcam plc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.0358 | 2014-03-19 |
Last Dividend | £0.0443 | 2020-03-19 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | £0.836 | -- |
Avg. Dividend % Per Year | 0.02% | -- |
Score | 3.14 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 2.72 | |
Div. Directional Score | 6.68 | -- |
Year | Amount | Yield |
---|---|---|
2014 | £0.122 | 1.59% |
2015 | £0.124 | 1.78% |
2016 | £0.117 | 1.23% |
2017 | £0.114 | 1.26% |
2018 | £0.158 | 1.12% |
2019 | £0.157 | 1.10% |
2020 | £0.0443 | 0.24% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.000600 | 1.500 | 9.99 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.000268 | 1.200 | 9.99 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.000380 | 1.500 | -1.107 | -1.660 | [0.1 - 1] |
payoutRatioTTM | 22.73 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.354 | 0.800 | 8.23 | 6.58 | [1 - 3] |
quickRatioTTM | 0.993 | 0.800 | 8.86 | 7.09 | [0.8 - 2.5] |
cashRatioTTM | 0.418 | 1.500 | 8.79 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.211 | -1.500 | 6.48 | -9.72 | [0 - 0.6] |
interestCoverageTTM | 9.21 | 1.000 | 7.70 | 7.70 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0180 | 2.00 | 9.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.302 | -1.500 | 8.79 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.779 | 1.000 | 0.352 | 0.352 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.104 | 1.000 | 9.92 | 9.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.121 | 1.000 | -0.440 | -0.440 | [0.2 - 2] |
assetTurnoverTTM | 0.446 | 0.800 | -0.360 | -0.288 | [0.5 - 2] |
Total Score | 10.65 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 16 326 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.000380 | 2.50 | -0.712 | -1.660 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0180 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
payoutRatioTTM | 22.73 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -761.25 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0572 | 1.000 | -1.070 | 0 | [0.1 - 0.5] |
Total Score | 2.72 |
Abcam plc
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators